4.5 Article

New P2Y12 inhibitors

Journal

HEART
Volume 97, Issue 15, Pages 1262-1267

Publisher

B M J PUBLISHING GROUP
DOI: 10.1136/hrt.2009.184242

Keywords

-

Funding

  1. AstraZeneca
  2. Eli Lilly
  3. Daiichi Sankyo
  4. Medicines Company
  5. Novartis
  6. Sanofi Aventis
  7. Bristol Myers Squibb
  8. GlaxoSmithKline
  9. Eisai
  10. Schering Plough
  11. Merck
  12. Teva
  13. Dynabyte Accumetrics
  14. Medscape
  15. Eli Lilly/Daiichi Sankyo
  16. Accumetrics

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available